How The US FDA Honed Remote Tools To Assess Facilities During COVID Inspection Hiatus

Remote alternatives to inspections played a key role in the US Food and Drug Administration's efforts to assess drug manufacturing facilities during the pandemic as participants gained experience with them, according to agency and industry officials who reflected on their learnings at a recent conference.

As COVID-19-related travel restrictions led to increased reliance on inspection alternatives, participants found ways to enhance them by, for example, ensuring streaming video signal quality, keeping remote assessments properly focused, leveraging